Back
Armata Pharmaceuticals Stock Price Chart

Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
22
ARMP
Armata Pharmaceuticals
Last Price:
$1.39
Seasonality Move:
1.78%
7 Day Trial
ALL ACCESS PASS
$
7

AI Marketing Is Moving Fast–Don't Miss Your Window!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing slight selling pressure.
Armata Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.71 | Sell |
20-day SMA: | 1.88 | Sell |
50-day SMA: | 1.98 | Sell |
200-day SMA: | 2.31 | Sell |
8-day EMA: | 1.68 | Sell |
20-day EMA: | 1.82 | Sell |
50-day EMA: | 1.95 | Sell |
200-day EMA: | 2.26 | Sell |
Armata Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 26.33 | Sell |
Chaikin Money Flow: | -12898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.73 - 2.11) | Sell |
Bollinger Bands (100): | (1.88 - 2.28) | Sell |
Armata Pharmaceuticals Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 1.46 while ARMP 8-day simple moving average is 1.71, which is a Sell signal.
-
The stock price of ARMP is 1.46 while Armata Pharmaceuticals 20-day SMA is 1.88, which makes it a Sell.
-
Armata Pharmaceuticals 50-day simple moving average is 1.98 while ARMP share price is 1.46, making it a Sell technically.
-
ARMP stock price is 1.46 and Armata Pharmaceuticals 200-day simple moving average is 2.31, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Sell
22
Armata Pharmaceuticals (ARMP)
is a Sell
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a SellThe current Armata Pharmaceuticals [ARMP] share price is $1.46. The Score for ARMP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
52.8M
Price in USD:
1.46
Share Volume:
47.3K
Armata Pharmaceuticals 52-Week Range
52-Week High:
4.25
52-Week Low:
1.34
Sell
22
Armata Pharmaceuticals (ARMP)
is a Sell
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?The Armata Pharmaceuticals stock price is 1.46 USD today.
-
Will ARMP stock go up or go down?Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Armata Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is overvalued.
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 1.46 while ARMP 8-day exponential moving average is 1.68, which is a Sell signal.
-
The stock price of ARMP is 1.46 while Armata Pharmaceuticals 20-day EMA is 1.82, which makes it a Sell.
-
Armata Pharmaceuticals 50-day exponential moving average is 1.95 while ARMP share price is 1.46, making it a Sell technically.
-
ARMP stock price is 1.46 and Armata Pharmaceuticals 200-day simple moving average is 2.26, creating a Sell signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
-
ARMP Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Armata Pharmaceuticals is a Sell
-
Armata Pharmaceuticals Relative Strength Index (RSI) is 26.33, which suggest Armata Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Armata Pharmaceuticals is (1.73 - 2.11), which suggest Armata Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Armata Pharmaceuticals is (1.88 - 2.28), which suggest Armata Pharmaceuticals is a Sell
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.